Who is this study for: Patients with myelofibrosis
Status: Recruiting
Start Date: February 9, 2021
Intervention Type: Drug, Radiation, Biological, Procedure
Study Drugs: Sargramostim, Fludarabine, Melphalan, Tacrolimus, Mechlorethamine, Mycophenolate Mofetil, Mycophenolic
Phase: Phase 2